Navigation Links
CoreRx, Inc. Announces Plans for Expansions to Meet the Needs of Growing Pharmaceutical Formulation Development Business
Date:6/15/2009

Formulation Development firm CoreRx announces new facility which will add capacity, additional capabilities to growing laboratory in order to meet growing customer demands.

Tampa, FL (Vocus) June 15, 2009 -- CoreRx, Inc. has announced plans to purchase a new facility which will more than triple the company's previous capacity and will accommodate projected growth through 2015.

The 80,000 sq ft building will be remodeled and up-fitted and expanded to ultimately house current staff plus fifty-five new employees. The founders of CoreRx intend to locate the company headquarters at the site, as well as utilize the space for contract manufacturing and formulation research and development. The additional jobs will include expanding the management team, research scientists, research and manufacturing employees, as well as staff for facilities and maintenance. Dr. Todd R. Daviau, President and CEO of CoreRx is hopeful that many of the employees can be hired locally. "I have been very impressed with the assistance that CoreRx is receiving on the state and local level. This is a very important step for our company. We are enthusiastic about the future of CoreRx as well as the positive contribution we hope to make to the community. We wish to express our sincere appreciation to the Greater Tampa Chamber Committee of One Hundred, and all of the County and State officials without whose dedicated efforts this project might not have materialized."

Work on the 80,000 sq ft building will begin in the near future. Plans for the $5Million renovation are being completed at this time. It is hoped that portions of the building can be occupied later this year and the entire expansion can be completed in about 18 months. The average projected wages for the jobs at the facility are projected to be in excess of $65,000.00 per year.

About CoreRx, Inc.
CoreRx™ focuses on supporting and streamlining the drug development process for biotechnology and pharmaceutical innovators by offering services such as pre-formulation/formulation development, analytical development, clinical manufacturing and validation engineering. We have a proven track record and extensive expertise providing comprehensive drug development services to biotechnology and pharmaceutical companies worldwide.

CoreRx, Inc. is a CGMP-compliant contract development and manufacturing facility. From its inception in 2006, CoreRx has been dedicated to solving scientific problems and providing expert pharmaceutical services to businesses required to meet the growing demand of pharmaceutical companies.

For more information, visit their website CoreRx, Inc. or call (813) 514-9399.

# # #

Read the full story at http://www.prweb.com/releases/pharmaceutical/formulation/prweb2531604.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Cumberland Pharmaceuticals Announces FDA Approval of Caldolor(TM)
2. Next Stage Solutions Announces Three New Financial Services For Emerging Business
3. Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
4. Krohne Announces Podcast on Energy Management
5. invivodata Announces ePROficiency 2009 Web Seminar Series
6. Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors
7. BioLife Solutions Announces Validation and Start-Up of New Internal Manufacturing Facility for Serum-Free Cell and Tissue Biopreservation Media Products
8. MEDomics Announces MitoDx(TM), the First NextGen Mitochondrial Genome Diagnostic Test
9. HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University
10. ADVENTRX Pharmaceuticals Announces Financing
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CoreRx, Inc. Announces Plans for Expansions to Meet the Needs of Growing Pharmaceutical Formulation Development Business
(Date:10/11/2017)... ... 2017 , ... Proscia Inc ., a data solutions ... “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, Managing ... how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published in ... and fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched ... , After comparing the results from the fresh and frozen transfer cohorts, the ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building and cooking events company, ... today. The bold new look is part of a transformation to increase awareness, ... significant growth period. , It will also expand its service offering from its signature ...
Breaking Biology Technology:
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative ... ... Maldives Immigration ... Algeen (small picture on the right) have received the IAIR award for ...
(Date:3/23/2017)... PUNE, India , March 23, 2017 The report ... Equipment, Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by ... growing at a CAGR of 29.63% between 2017 and 2022. ... ... Logo ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
Breaking Biology News(10 mins):